Synergistic cytotoxicity and co-autophagy inhibition in pancreatic tumor cells and cancer-associated fibroblasts by dual functional peptide-modified liposomes-Reference-Cited by-同舟云学术

Synergistic cytotoxicity and co-autophagy inhibition in pancreatic tumor cells and cancer-associated fibroblasts by dual functional peptide-modified liposomes

Published:2019-11 Issue: Volume:99 Page:339-349
ISSN:1742-7061
Container-title:Acta Biomaterialia
language:en
Short-container-title:Acta Biomaterialia

Author:

Chen Xiaoxiao,Yu Qianwen,Liu Yinke,Sheng Qinglin,Shi Kairong,Wang Yang,Li Man,Zhang Zhirong^ORCID,He Qin^ORCID

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Molecular Biology,Biomedical Engineering,Biochemistry,Biomaterials,General Medicine,Biotechnology

Reference44 articles.

1. Cancer statistics, 2018;Siegel;CA Cancer J. Clin.,2018

2. An imaging-based review of systemic therapies and associated toxicities in metastatic pancreatic cancer as per the 2018 ASCO guidelines: what every radiologist should know;Smith;Abdom. Radiol. (NY),2019

3. Pancreatic cancer: from state-of-the-art treatments to promising novel therapies;Garrido-Laguna;Nat. Rev. Clin. Oncol.,2015

4. Comparative effectiveness of nab-paclitaxel plus gemcitabine vs FOLFIRINOX in metastatic pancreatic cancer: a retrospective nationwide chart review in the United States;Kim;Adv. Ther.,2018

5. A comparative study of neoadjuvant treatment with gemcitabine plus nab-paclitaxel versus surgery first for pancreatic adenocarcinoma;Ielpo;Surg. Oncol.,2017

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanomedicine-induced programmed cell death in cancer therapy: mechanisms and perspectives;Cell Death Discovery;2024-08-29

2. Laser-enzyme dual responsive liposomes to regulate autophagy in synergy with phototherapy for melanoma treatment;Journal of Drug Targeting;2024-08-05

3. Theranostic nanoparticles for detection and treatment of pancreatic cancer;WIREs Nanomedicine and Nanobiotechnology;2024-07

4. Conquering chemoresistance in pancreatic cancer: Exploring novel drug therapies and delivery approaches amidst desmoplasia and hypoxia;Cancer Letters;2024-04

5. Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches;Cancer Letters;2024-04